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It remains unclear whether Bacillus Calmette-Guérin
(BCG) vaccination is related to the development of
childhood asthma. Meta-analyses on this topic have come
to mixed conclusions. Between 1949 and 1974, a BCG
vaccination program was conducted in Québec targeting
neonates and school-age children. To investigate the effect
of BCG vaccination on asthma, we assembled a retrospec-
tive cohort of subjects born in Québec in 1974 through
the linkage of several administrative medical and demo-
graphic databases. BCG vaccination status, asthma-related
events (medical services, hospitalizations, emergency
department visits), and potential confounders were
obtained for each subject until 1994. Logistic regression
was used to estimate odds ratios (OR) and 95% confidence
intervals (CI) adjusting for gender, birth weight for gesta-
tional age, number of older siblings, parents’ age, family
income, and urban/rural residency. Among 90,060 indivi-
duals born in Québec in 1974, at or after 32 weeks of
gestation, probabilistic linkage resulted in a cohort of
81,496 subjects (90.5%). Vaccination or asthma status
could not be determined for 4,566 subjects. Among the
remaining 76,930 subjects, 51% were males. Subjects
vaccinated with BCG within their first year constituted
43% of the cohort, whereas those vaccinated later
amounted to 3.5%. Those who had 2 or more asthma-
related medical services or at least 1 hospitalization were
considered asthmatics, representing 7.7% of the cohort.
A slightly lower asthma risk was observed among those
vaccinated as compared with non-vaccinated subjects; the
adjusted OR was 0.94 (95% CI: 0.89, 0.99). The lack of
information on some potential confounding factors is
a limitation. Such information has been gathered by
telephone interviews with a subset of subjects, and will
allow further adjustment of the measure of association.
So far, these preliminary results are in support of the
immunological hypothesis that BCG vaccination in early
life may influence immune maturation and prevent
asthma.
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